Combination Therapies with Kinase Inhibitors for Acute Myeloid Leukemia Treatment

Targeting kinase activity is considered to be an attractive therapeutic strategy to overcome acute myeloid leukemia (AML) since aberrant activation of the kinase pathway plays a pivotal role in leukemogenesis through abnormal cell proliferation and differentiation block. Although clinical trials for...

Descripción completa

Detalles Bibliográficos
Autor principal: Takahashi, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297912/
https://www.ncbi.nlm.nih.gov/pubmed/37367084
http://dx.doi.org/10.3390/hematolrep15020035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297912/
https://www.ncbi.nlm.nih.gov/pubmed/37367084
http://dx.doi.org/10.3390/hematolrep15020035

Ejemplares similares